The Hsa_circ_0091579/miR-940/TACR1 Axis Regulates the Development of Hepatocellular Carcinoma

Peiqiang Jiang1, Wei Han1, Yu Fu1

  • 1Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin, People's Republic of China.

Insights

Circular RNA hsa_circ_0091579 (circ_0091579) promotes hepatocellular carcinoma (HCC) development by regulating the miR-940/TACR1 axis. Knockdown of circ_0091579 inhibits HCC progression and tumor growth, revealing a novel mechanism in HCC pathogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer development.
  • The specific circRNA hsa_circ_0091579 (circ_0091579) is dysregulated in hepatocellular carcinoma (HCC).
  • The precise mechanism by which circ_0091579 influences HCC progression remains largely unelucidated.

Purpose of the Study:

  • To investigate the role and underlying mechanism of circ_0091579 in the development of hepatocellular carcinoma (HCC).
  • To explore the regulatory relationship between circ_0091579, microRNA-940 (miR-940), and tachykinin-1 receptor (TACR1) in HCC.

Main Methods:

  • Quantitative reverse transcription-polymerase chain reaction and Western blot were used to measure gene and protein expression.
  • Cellular assays (viability, migration, invasion, colony formation, cell cycle, apoptosis) were performed to assess functional impacts.
  • Dual-luciferase reporter assays confirmed interactions between circ_0091579, miR-940, and TACR1.
  • In vivo xenograft models were utilized to evaluate the anti-tumor effects of circ_0091579 knockdown.

Main Results:

  • circ_0091579 expression was significantly elevated in HCC tissues and cells.
  • Silencing circ_0091579 suppressed HCC cell proliferation, migration, invasion, and colony formation, while inducing apoptosis and cell cycle arrest.
  • circ_0091579 directly targets miR-940, and miR-940 targets TACR1, forming a regulatory axis that influences HCC development.
  • Knockdown of circ_0091579 inhibited tumor growth in vivo.

Conclusions:

  • circ_0091579 promotes HCC progression by regulating the miR-940/TACR1 axis.
  • Downregulation of circ_0091579 exhibits anti-tumor effects in HCC.
  • These findings highlight a novel pathogenic mechanism of circ_0091579 in hepatocellular carcinoma.
Abstract

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K